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Abstract
Background: Dementia is a chronic illness associated with a progressive loss of cognitive and
intellectual abilities, such as memory, judgment and abstract thinking.
The objective of this study was to assess the health utilities of patients with dementia in Europe
and identify the key factors influencing their Health-Related Quality of Life (HRQol).
Methods: This study used cross-sectional data from the Odense study; a Danish cohort of patients
aged 65–84 living in Odense, Denmark. A total of 244 patients with mild to severe dementia were
interviewed together with a caregiver about their health status and activities of daily living (ADL).
Alzheimer's disease was diagnosed according to the NINCDS-ADRDA criteria for probable
dementia. Vascular dementia and other types of dementia were diagnosed according to the DSM-
IIIR criteria. Severity of dementia was defined by score intervals on the Mini Mental State
Examination score: mild (MMSE 20–30), moderate (MMSE 10–19), and severe (MMSE 0–9). Based
on the ADL information, the patients' dependency level was defined as either dependent or
independent. Questions from the Odense Study were mapped into each of the five dimensions of
the EQ-5D in order to assess patients' HRQol. Danish EQ-5D social tariffs were used to value
patients' HRQol.
A regression analysis of EQ-5D values was conducted with backward selection on gender, age,
severity, ADL level and setting in order to determine the main factor influencing HRQoL.
Results: The EQ-5D weight in patients independent upon others in ADL was 0.641 (95% CI:
[0.612–0.669]), and in those dependent upon others was 0.343 (95% CI: [0.251–0.436]).
Conclusion: Dependency upon others to perform ADL was the main factor affecting HRQoL.
Background
Dementia is a chronic illness associated with a progressive
loss of cognitive and intellectual abilities, such as mem-
ory, judgment and abstract thinking. Cognitive
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disabilities are those that impact an individual's ability to
access, process, or remember information. People with
profound cognitive disability will need assistance with
nearly every aspect of daily living. The most visible mani-
festation of dementia is the progressive inability – propor-
tional to the severity of the disease – to perform activities
of daily living (ADL) and the subsequent loss of inde-
pendence [1]. Progressive deterioration in the cognitive,
functional and behavioural domains eventually brings
patients to the later stages of dependency and, in most
cases, to institutionalisation, which is linked to an
increased need in caregiver assistance [2]. A patient's level
of dependency is a global measurement reflecting a cer-
tain level of severity, resource consumption and Quality-
of-Life (QoL) [3].
Measuring the QoL of patients suffering from dementia
can take several forms. Firstly, QoL can be measured using
generic health indices like the other disease specific meas-
ures. Recently several scales have been developed and val-
idated specifically for dementia patients such as the
Quality of Life-Alzheimer's Disease (QOL-AD). Another
alternative to assess QoL is to use utility measurements,
which are preference-based [4]. Preference-based meas-
ures evaluate the patient's preference for a health state
instead of measuring the frequency and the severity of
symptoms or disabilities. In order to use quality-adjusted
life years (QALYs) as outcome measures for cost-effective-
ness analyses, utility-weighted measures of Health-
Related Quality-of-Life (HRQoL) are required. These
attribute a single number to a health state using a com-
mon unit of measure allowing comparison between dif-
ferent strategies [5]. In general, however, HRQoL is not as
broad a concept as QoL. One of the more reliable and
newer tools used to measure HRQoL in a wide range of
health conditions and treatments including dementia is
the EQ-5D [6]. It is a generic measure designed to comple-
ment disease specific outcome measures and health char-
acterises on five dimensions: mobility, self-care, ability to
perform usual activities, pain, and anxiety/depression. It
provides a descriptive health profile and a single index
value for health status and, as such, it can be used to esti-
mate utility in pharmacoeconomic evaluations of new
pharmacological treatments.
Health utilities have already been measured in AD in the
US and Canada using the Health Utility Index (HUI) [7].
In the UK, the EuroQol instrument has been used to
investigate whether HRQol data could be obtained from
proxies, such as family caregivers [8]. In France, the Euro-
Qol instrument has been administered to patients with
dementia in order to determine the feasibility, reliability,
and validity of the French version of the EuroQol instru-
ment [9]. However, health utilities are not reported from
the two latter studies. Furthermore, HRQol data are
needed in order to carry out cost-effectiveness analysis for
a Danish setting.
Based on data collected alongside an epidemiological
study conducted in Odense Denmark, we attempted to
assess the health utilities of patients with dementia and
identify the key factors influencing their HRQoL.
Methods
Population
Data were derived from the Odense study, an epidemio-
logical survey in which the objective was to estimate the
prevalence and incidence of dementia in Denmark
[10,11] In this study, a total of 244 patients with dementia
agreed to participate in an interview accompanied by a rel-
ative or caregiver. The study was approved by the Scien-
tific-Ethical Committee of the Counties of Funen and
Vejle, Denmark, and by the Danish Data Protection
Agency.
Demented patients were classified by type of dementia
and by severity of dementia. Alzheimer's disease (AD) was
diagnosed according to the NINCDS-ADRDA criteria for
probable dementia [12]. Vascular dementia and other
types of dementia were diagnosed according to the DSM-
IIIR criteria [13]. Severity of dementia was diagnosed
according to the Clinical Dementia Rating (CDR) scale
[14] and the Mini Mental State Examination (MMSE)
[15]. The complete examination programme is described
in Andersen, Lolk et al, 1997 [10].
Assessments
All interviews were conducted by a certified nurse in the
patient's home., Patient's and caregiver's socio-economic
and socio-demographic status as well patients' health sta-
tus and ADL were recorded. In the event that a relative was
not present during the interview, a professional caregiver
verified information provided by the patient.
Each interview included the following information:
- sociodemographic questions (age, gender, setting).
- activity of daily living (ADL) questionnaire using 7 items
describing patients' ability to perform physical activities
(personal care, dressing, mobility and personal toiletry)
and psychosocial activities (activities in the home and
hobbies inside and outside of the home). Each activity
was scored using a four-point Likert scale anchored at the
ends with 1 = "Unable to perform the activity" and 4 =
"Perform the activity without help from others". The
physical ADL ranged between 4 (worst state) and 16 (best
state), while the psychosocial ADL scored between 3
(worst state) and 12 (best state) [16].Health and Quality of Life Outcomes 2004, 2:52 http://www.hqlo.com/content/2/1/52
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- Questions mapped into each of the five dimensions of
the EQ-5D: mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression as presented in the Table
1[17].
For the mobility dimension of the EuroQol instrument,
we assumed that patients that were able to walk without
assistance from others had no problems in performing
this activity, whereas patients who were unable to walk
unassisted were classified as confined to bed. Patients that
needed help from others were classified as having some
mobility problems.
Two questions from the ADL instrument in the Odense
Study were used to classify patients on the EuroQol per-
sonal care dimension. Patients that performed both activ-
ities without help from others were classified as having no
problems on this dimension. Patients in need of help with
either personal care or dressing or both were classified as
having some problems. Only patients unable to wash and
dress without help from others were classified as such on
the EuroQol instrument.
The patient's ability to carry out hobbies in the home was
used as a proxy for their ability to perform usual activities.
For the pain/discomfort dimension of the EuroQol instru-
ment, it was assumed that patient assessment of their own
health status covered this dimension. Therefore, if they
found their health status to be very good they were classi-
fied as having no pain or discomfort. A good or fair assess-
ment was categorised as having moderate pain or
discomfort, whereas a poor assessment was assumed to
correspond to extreme pain or discomfort.
In the Odense Study, patients stated how often they expe-
rienced emotional problems, whereas the health state
being described by the EuroQol instrument refers to the
patient's health at the time of filling in the instrument.
Thus, the questions in the Odense Study included an
aspect of time that the EuroQol does not cover. To over-
come this, it was assumed that the occurrence of emo-
tional problems converts to the degree of anxiety or
depressions. That is, patients that never experience emo-
tional problems were assumed not to be anxious or
depressed, whereas patients that sometimes or often expe-
rience problems converted to moderate or extreme anxiety
or depression, respectively.
The procedure of mapping returned a five-digit code,
where the first digit referred to the patient's mobility level;
the second to the patient's level on personal care; and so
forth. This five-digit code described a health state for
which we looked up the HRQoL utility weight in a table
of EQ-5D tariffs. The EQ-5D tariffs take values between
zero and one, where zero is the worst imaginable health
status, and one is the best imaginable health status. We
Table 1: Mapping questions from the Odense Study into the EQ-5D
EQ-5D The Odense Study
Mobility Mobility
1. I have no problems in walking around. • Without help from others.
2. I have some problems in walking around. • Needs some help from others.
• Needs help from others.
3. I am confined to bed. • Unable to walk around without help.
Personal care Personal care/dressing
1. I have no problems with self-care. • Without help from others.
2. I have some problems with self-care. • Needs some help from others.
• Needs help from others.
3. I am unable to wash or dress myself. • Unable to wash or dress without help.
Usual activities Hobbies in the home
1. I have no problems with performing my usual activities. • Without help from others.
2. I have some problems with performing my usual activities. • Needs some help from others.
• Needs help from others.
3. I an unable to perform my usual activities. • Unable to perform hobbies in the home.
Pain/discomfort Patient's assessment of own health status
1. I have no pain or discomfort. • Very good.
2. I have moderate pain or discomfort. • Good/fair.
3. I have extreme pain or discomfort. • Poor.
Anxiety/depression Patient's experience of emotional problems
1. I am not anxious or depressed. • Never.
2. I am moderately anxious or depressed. • Sometimes.
3. I am extremely anxious or depressed. • Often.Health and Quality of Life Outcomes 2004, 2:52 http://www.hqlo.com/content/2/1/52
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used Danish EQ-5D tariffs from a survey based on the
time trade-off technique [18].
Patients classification
Based on their cognitive and functional scores patients
were classified by severity and dependency level.
Severity Status
The severity of a patient's dementia was defined by score
intervals on the MMSE [15]. Those scoring ≥20 were con-
sidered as having mild dementia, while patients scoring
between 10 and 19 were classified as having moderate
dementia. Patients scoring ≤9 were classified as suffering
from severe dementia. MMSE scores were not available for
30 patients (21 AD patients and 9 patients suffering from
vascular dementia). In order to determine these patients
degree of dementia we used the CDR score to classify
them into the above three severity groups. Patients with a
CDR score of 0.5 were classified as mild, patients with a
CDR of 1 were classified as moderate and patients with a
CDR of 2 to 3 were classified as severe [19].
Dependency Status
Patients were classified by their ability to perform physical
and psychosocial activities of daily living (ADL) This
resulted in a classification of either dependent or inde-
pendent [3]. A binary variable was based on a non-hierar-
chical cluster analysis [20]. Firstly, we identified possible
initial seeds for the analysis. The seeds were identified
from a cross table of the physical ADL score and the psy-
chosocial ADL score. Combinations of the physical and
psychosocial ADL scores with five or more observations
were included in the cluster analysis as possible seeds. Sec-
ondly, we carried out the cluster analysis using the PROC
FASTCLUS procedure in SAS 8.2 (SAS Institute Inc., Cary,
NC, USA) in order to identify two clusters.
One cluster included patients with low scores on both the
physical and psychosocial ADL scales. As low scores on
both instruments meant that patients required help from
others in performing the activities in question, they were
classified as "Dependent". The other cluster included
patients with high scores on both ADL scales and they
were classified as "Independent". As these were composite
criteria, the characteristics of the two groups of depend-
ency were analysed.
Statistical Analysis
After analysing the descriptive results of the EQ-5D scores,
we performed a regression analysis of EQ-5D scores on
sociodemographic and clinical characteristics. Sociode-
mographic characteristics included gender, age and setting
(living in the community or institutionalised) and clinical
characteristics took into account the level of severity
(Mild, Moderate, and Severe), the type of dementia (AD,
vascular or other) and ADL status (independent or
dependent).
The regression analysis was performed with backward
selection (level 5%) in order to determine the main fac-
tors influencing QoL.
Because of heteroscedasticity, we estimated the hetero-
scedasticity consistent covariance matrix, which was used
to calculate test statistics for the coefficients.
Observations with missing data were automatically
excluded from the analyses. That is, observations with
insufficient information to establish a EQ-5D weight, e.g.
that information was lacking to determine a patient's
mobility level on the EQ-5D instrument.
Results
Table 2 illustrates the characteristics of patients included
in the Odense Study by type of dementia. Of the 244
patients, 164 (67%) suffered from Alzheimer's disease
(AD) and 80 suffered from vascular or other types of
dementia. On average, AD patients were 3.9 years younger
(95% confidence interval: [2.5 – 5.3]) than patients suf-
fering from vascular or other types of dementia and more
AD patients lived in a nursing home (p = 0.03). The
remainder of patient characteristics in Table 2 did not sig-
nificantly differ between the two groups.
Tables 3 and 4 show the results from the cluster analysis,
which was used to classify patients, according to their ADL
status, as either independent or dependent in performing
activities of daily living. Table 3 presents cluster character-
istics. Of the 244 patients with dementia, 38 (16%) were
classified as dependent, and 206 (84%) were classified as
independent in the performance of ADL. Dependent
patients were, on average, more severely stricken and
institutionalised than independent patients.
Table 4 shows the number of patients by dependency sta-
tus and type of dementia. Due to of missing data, EQ-5D
values were estimated for only 211 patients upon 244
demented patients. Results of comparison of EQ-5D value
in different subgroups of patients were shown in Table 5.
Patient QoL seems to decrease when severity and depend-
ency increase as well as when patients are
institutionalised.
Table 6 shows the results of a regression analyses. The
results from the full model that included all predictors, as
well as results from the reduced model that included only
significant predictors are presented.
Patients dependent upon others to perform activities of
daily living clearly had a lower QoL than independentHealth and Quality of Life Outcomes 2004, 2:52 http://www.hqlo.com/content/2/1/52
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Table 2: Background Characteristics of Patients in the Odense Study
Patients suffering from 
Alzheimer's disease
Patients suffering from vascular 
or other types of dementia
All patients suffering from 
dementia
Number of patients 164 (67.2%) 80 (32.8%) 244
Number of females 89 (54.3%) 33 (41.3%) 122 (50.0%)
Mean (SD) age in years 79.4 (5.14) 75.5 (5.21) 78.1 (5.47)
Mean (SD) MMSE score 20.6 (4.62) 21.6 (4.96) 21.0 (4.75)
Severity of dementia
Mild (MMSE 20–30) 91 (55.5%) 49 (61.3%) 140 (57.4%)
Moderate (MMSE 10–19) 51 (31.1%) 23 (28.8%) 74 (30.4%)
Severe (MMSE 0–9) 22 (13.4%) 8 (10.0%) 30 (12.3%)
Mean (SD) physical ADL score 14.1 (3.08) 13.7 (2.96) 14.0 (3.04)
Mean (SD) psychosocial ADL score 9.3 (2.81) 9.0 (2.39) 9.2 (2.68)
Living in the community 132 (80.5%) 73 (91.3%) 205 (84.0%)
Table 3: Cluster Description
Dependent Independent p-value
Number of patients 38 (16%) 206 (85%)
Number of females 17 (45%) 105 (51%) 0.4801
Mean (SD) age in years 79.3 (5) 77.9 (5) 0.1493
Number of AD patients 24 (63%) 140 (68%) 0.5622
Mean (SD) MMSE score 16.8 (6) 21.4 (4) <0.0001
Mean (SD) physical ADL score 7.9 (2) 15.1 (1) <0.0001
Mean (SD) psychosocial ADL score 4.7 (2) 10.1 (2) <0.0001
Number of patients living in the community 16 (42%) 189 (92%) <0.0001
Table 4: Number of Patients by Dependency Status and Type of Dementia
ADL status Patients suffering from 
Alzheimer's disease
Patients suffering from vascular or 
other types of dementia
All
Dependent 24 (15%) 14 (18%) 38 (16%)
Independent 140 (85%) 66 (83%) 206 (84%)
All 164 (100%) 80 (100%) 244 (100%)
Table 5: Mean EQ-5D weights by patient subgroups
NM e a n S D
Severity Subgroups
Mild MMSE > 20 135 0.636 (0.2109)
Moderate 9 < MMSE < 20 64 0.596 (0.2152)
Severe MMSE < 10 12 0.486 (0.2191)
Dependency Subgroups
Independent 193 0.641 (0.1952)
Dependent 18 0.343 0.2324)
Setting subgroups
Community 191 0.621 (0.2173)
Institution 20 0.564 (0.1861)Health and Quality of Life Outcomes 2004, 2:52 http://www.hqlo.com/content/2/1/52
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patients. The QoL of independent patients suffering from
dementia as assessed by their capacity to perform activi-
ties of daily living was 0.641 (95% confidence interval:
[0.612 – 0.669]) whereas the QoL of dependent patients
for the same assessment was 0.343 (95% CI: [0.251 –
0.436]). Severity of dementia and setting has no statisti-
cally significant impact on QoL.
Discussion
For the first time, this study provides health utilities for
patients with dementia in Denmark. This study has shown
that the factor that most affects the HRQoL of a patient
with dementia is their dependency status as defined based
by their ability to perform activities of daily living. The
type of dementia doesn't seem to have a great an influence
on patient's HRQoL, and severity does not appear to dis-
criminate significantly between health utilities. However,
due to missing data – particularly among patients with
severe dementia – caution must be exercised when inter-
preting the results.
In the utility results previously measured by Neumann et
al. [7] using the Health Utility Index (HUI), AD patients'
utilities decreased significantly with their severity levels.
However, this could be explained by the fact that the EQ-
5D does not consider cognition as a separate attribute,
unlike the HUI scales. Despite this difference, results
obtained with the HUI and the EQ-5D instruments were
within the same range.
As the EQ-5D values were estimated based on mapped
questions, it raises the possibility of quotation bias and
goodness of fit. Also, both patients and caregivers
answered questions. Yet, with AD – and especially when
patients are severely demented – it is impossible to collect
non-proxy measurements in the later stages. The same
methodology was performed in previous evaluations
without knowing the impact of the difference between
caregivers' and patients' perceptions.
A particular strength of this study was that all data have
been collected in conjunction with an epidemiological
study wherein patients with dementia had been examined
carefully and dementia criteria were explicitly stated.
Conclusion
Measuring HRQoL is as important as measuring disease
severity, progression, symptom response, cognition and
behavioural disturbance when assessing the impact of dis-
ease and determining proper intervention in the treat-
ment and management of dementia. However, HRQoL is
difficult to assess in a disease such as dementia for which
patients suffer from cognitive disabilities. Based on study
results and as previously shown by Kurz et al. [3], depend-
ency level greatly influences patients' HRQoL and, when
viewed as a global measure, reflects a certain level of
HRQoL. Determining dependency levels could be consid-
ered as an indirect evaluation of HRQol. Other studies
with disease specific questionnaires such as QoL-AD are
needed to confirm these findings.
Abbreviations
ADL Activities of Daily Living
EQ-5D EuroQol – Five Dimension Scale
EuroQol EuroQol Scale
DSM-IIIR Diagnostic and Statistical Manual of Mental
Disorders 3rd edition
HRQol Health-Related Quality of Life
MMSE Mini Mental State Examination
Table 6: Results of the Regression Analysis of EQ-5D TTO Tariff on Severity of Dementia, ADL Status and Setting (n = 211)
Full model Reduced model
Variable Coefficient Asymptotic 
standard error
p-value Coefficient Asymptotic 
standard error
p-value
Constant 0.579 0.0371 <0.0001 0.641 0.0140 <0.0001
Gender (0 = male, 1 = female) 0.045 0.0266 0.0948 - - -
Age 0.003 0.0029 0.3553 - - -
Type of dementia (0 = Other, 1 = AD) 0.006 0.0327 0.8522 - - -
Severity of dementia
Moderate 0.043 0.0280 0.1258 - - -
Severe -0.079 0.0534 0.1405 - - -
Dependency status (0 = independent, 1 = dependent) -0.289 0.0534 <0.0001 -0.297 0.0551 <0.0001
Setting (0 = community, 1 = nursing home) 0.027 0.0368 0.4672 - - -
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